REMED Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 107

Employees

  • Stock Symbol
  • 302550

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.96
  • (As of Wednesday Closing)

REMED General Information

Description

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Contact Information

Website
www.remed.kr
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 21-7, Wiryeseo-1-gil
  • Sujeong-gu
  • Seongnam, Gyeonggi 13647
  • South Korea
+82
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 21-7, Wiryeseo-1-gil
  • Sujeong-gu
  • Seongnam, Gyeonggi 13647
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

REMED Stock Performance

As of 18-Nov-2026, REMED’s stock price is $1.96. Its current market cap is $58M with 29.5M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.96 $1.94 $1.49 - $2.82 $58M 29.5M 442K $0.05

REMED Financials Summary

As of 30-Sep-2026, REMED has a trailing 12-month revenue of $19.8M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 53,723 58,113 72,698 79,743
Revenue 19,807 17,219 18,729 14,177
EBITDA 2,522 1,202 7,368 1,783
Net Income 1,449 370 5,256 610
Total Assets 39,476 37,437 40,098 42,726
Total Debt 4,421 3,773 5,278 12,949
Public Fundamental Data provided by Morningstar, Inc. disclaimer

REMED Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore REMED‘s full profile, request access.

Request a free trial

REMED Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore REMED‘s full profile, request access.

Request a free trial

REMED Patents

REMED Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023177040-A1 Magnetic field-generating therapeutic device having plurality of cooling structures Inactive 14-Mar-2022
US-20230285767-A1 Treatment device using magnetic field Pending 14-Mar-2022
WO-2023080310-A1 Air-cooled magnetic stimulator Inactive 03-Nov-2021
WO-2023054804-A1 Magnetic stimulation device comprising two or more applicators Inactive 30-Sep-2021
JP-7510729-B2 Magnetic field stimulation device Active 23-Oct-2020 A61N2/02
To view REMED’s complete patent history, request access »

REMED Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

REMED Investments (1)

REMED’s most recent deal was a Corporate Asset Purchase with Jaeseong Jeong (Office Building in Seongnam, South Korea) for . The deal was made on 22-Jul-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Jaeseong Jeong (Office Building in Seongnam, South Korea) 22-Jul-2020 Corporate Asset Purchase Buildings and Property
To view REMED’s complete investments history, request access »

REMED ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view REMED’s complete esg history, request access »

REMED Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Remed Japan Chuo-ku, Japan 2023

REMED FAQs

  • When was REMED founded?

    REMED was founded in 2003.

  • Where is REMED headquartered?

    REMED is headquartered in Seongnam, South Korea.

  • What is the size of REMED?

    REMED has 107 total employees.

  • What industry is REMED in?

    REMED’s primary industry is Therapeutic Devices.

  • Is REMED a private or public company?

    REMED is a Public company.

  • What is REMED’s stock symbol?

    The ticker symbol for REMED is 302550.

  • What is the current stock price of REMED?

    As of 18-Nov-2026 the stock price of REMED is $1.96.

  • What is the current market cap of REMED?

    The current market capitalization of REMED is $58M.

  • What is REMED’s current revenue?

    The trailing twelve month revenue for REMED is $19.8M.

  • What is REMED’s annual earnings per share (EPS)?

    REMED’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process